Psychopharmacology

, Volume 152, Issue 4, pp 353–361

The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers

  • K.A. Wesnes
  • T. Ward
  • A. McGinty
  • O. Petrini
Original Investigation

Abstract.

The effects of capsules containing 60 mg of a standardised extract of Ginkgo biloba (GK501) and 100 mg of a standardised extract of Panax ginseng (G115) on various aspects of cognitive function were assessed in healthy middle-aged volunteers. A double blind, placebo controlled, 14 week, parallel group, repeated assessment, multi-centre trial of two dosing regimens, 160 mg b.i.d. and 320 mg o.d. was conducted. Two hundred and fifty-six healthy middle-aged volunteers successfully completed the study. On various study days (weeks 0, 4, 8, 12 and 14) the volunteers performed a selection of tests of attention and memory from the Cognitive Drug Research computerised cognitive assessment system prior to morning dosing and again, at 1, 3 and 6 h later. The volunteers also completed questionnaires about mood states, quality of life and sleep quality. The Ginkgo/ginseng combination was found significantly to improve an Index of Memory Quality, supporting a previous finding with the compound. This effect represented an average improvement of 7.5% and reflected improvements to a number of different aspects of memory, including working and long-term memory. This enhancement to memory was seen throughout the 12-week dosing period and also after a 2-week washout. This represents the first substantial demonstration of improvements to the memory of healthy middle-aged volunteers produced by a phytopharmaceutical.

Cognitive function Ginkgo biloba Panax ginseng Computerised cognitive assessments Attention Working memory Secondary memory 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag 2000

Authors and Affiliations

  • K.A. Wesnes
    • 1
  • T. Ward
    • 1
  • A. McGinty
    • 1
  • O. Petrini
    • 2
  1. 1.Cognitive Drug Research Ltd, 24 Portman Road, Reading RG30 1EA, UK
  2. 2.Pharmaton SA, Lugano, Switzerland

Personalised recommendations